It also inhibits p‐STAT3 levels following treatment in PDAC cells (Figure 2) as well as inhibition of direct STAT3 targets including survivin, c‐Myc and Nanog in prostate cancer cells.16 The gene discussed is BIRC5; the disease is prostate cancer.